InsidersTradesSigma
Total declarations
Company
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Insider track record
Board DirectorDisclosed buys
0
Disclosed sells
0
T+90 hit rate
100%
T+90 mean return
+22.4%
Across 2 buy signals with a settled T+90 return. Return basis: close on the day after publication.
Signal history
Explore the full record of transactions filed by Cochran John, Director. Director active across 1 company, notably Aquestive Therapeutics, Inc.. Aggregated, 2 disclosures have been logged. Activity tracked since 10 May 2021. The latest transaction was filed on 10 May 2021 (Don). Regulator: SEC (Form 4). The full history is accessible without signup.
Declarations2 total
37,500 shares0Common StockSEC:0001214659-21-006162
37,500 shares0Common StockSEC:0001214659-21-006162:0
2 of 2 declarations
About Cochran John
John Cochran is a Director at Aquestive Therapeutics, Inc. In this role, he participates in the governance and strategy of the company. Aquestive Therapeutics, Inc. is a biopharmaceutical company specializing in developing innovative treatments. John Cochran brings his expertise in the health sector to help guide strategic decisions.
